Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 35.60B | 36.40B | 38.56B | 40.67B | 36.35B |
Gross Profit | 8.34B | 8.33B | 10.20B | 12.62B | 10.71B |
EBITDA | 6.06B | 6.19B | 7.53B | 9.29B | 7.26B |
Net Income | 1.37B | 1.16B | 2.26B | 3.61B | 2.43B |
Balance Sheet | |||||
Total Assets | 41.22B | 42.35B | 43.23B | 43.17B | 37.30B |
Cash, Cash Equivalents and Short-Term Investments | 19.52B | 18.38B | 17.91B | 19.17B | 13.64B |
Total Debt | 2.52B | 4.07B | 4.69B | 4.49B | 2.67B |
Total Liabilities | 10.15B | 11.39B | 12.70B | 13.60B | 10.77B |
Stockholders Equity | 29.78B | 29.67B | 29.24B | 28.30B | 25.32B |
Cash Flow | |||||
Free Cash Flow | 4.66B | 2.20B | -152.43M | 4.67B | 3.02B |
Operating Cash Flow | 6.34B | 5.70B | 4.04B | 9.37B | 6.67B |
Investing Cash Flow | -2.52B | -3.60B | -4.34B | -4.74B | -3.65B |
Financing Cash Flow | -2.68B | -1.64B | -974.83M | 881.97M | -456.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.42B | 10.50 | 3.64% | 25.26% | 65.66% | ||
76 Outperform | ¥23.62B | 18.10 | 2.99% | -1.20% | -30.27% | ||
74 Outperform | ¥8.30B | 9.19 | ― | 11.07% | 5.85% | ||
65 Neutral | ¥36.50B | 20.33 | 2.33% | -3.05% | 63.41% | ||
65 Neutral | ¥3.19B | 25.18 | ― | -3.96% | -73.55% | ||
63 Neutral | ¥2.22B | 7.99 | 3.49% | -2.89% | -144.95% | ||
61 Neutral | $17.75B | 12.56 | -5.49% | 3.02% | 1.43% | -14.12% |